ADTX - Why Aditxt Stock Is Volatile Today | Benzinga
Aditxt, Inc. (NASDAQ:ADTX) shares are volatile Tuesday after the company announced it will acquire Appili Therapeutics.
The Details:
Aditxt’s wholly owned subsidiary, Adivir, Inc. will acquire all issued and outstanding Class A common shares of Appili in the transaction.
Appili has developed FDA-approved Likmez (previously ATI-1501), its ATI-1701 biodefense program supported by a USD $14 million non-dilutive award from the U.S Department of Defense, and its ATI-1801 topical formulation targeting cutaneous leishmaniasis.
Aditxt shares are moving on heavy trading volume following the announcement. According to data from Benzinga Pro, more than 12 million shares have already been traded in the session, compared to the stock’s 100-day average of 579,243 shares.
Related News: What’s Going On With AMC ...